Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience

European Urology

Volumn 51, Issue 1, 2007, Pages 121-129

  Hsu, Chao Yu ^a   Joniau, Steven ^a   Oyen, Raymond ^a   Roskams, Tania ^a   Van Poppel, Hein ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

cT3; Locally advanced; Outcome; Prostate cancer

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COURSE EVALUATION; DIGITAL RECTAL EXAMINATION; DISEASE FREE INTERVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS;

ADULT; AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33751425667     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.05.024     Document Type: Article

References (24)

1. Van den Ouden D., and Schroder F.H. Management of locally advanced prostate cancer. World J Urol 18 (2000) 194-203
2. Maeda O., Meguro N., Saiki S., et al. Clinical outcome of radical prostatectomy for stage C prostate cancer: comparison with other treatment modalities. Hinyokika Kiyo 43 (1997) 457-460
3. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
4. Pilepich M.V., Caplan R., Byhardt R.W., et al. Phase III trial of androgen suppression using Goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of RTOG protocol 85-31. J Clin Oncol 15 (1997) 1013-1021
5. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
6. Hsu C.Y., Joniau S., and Van Poppel H. Radical prostatectomy for locally advanced prostate cancer: technical aspects of radical prostatectomy. EAU Update Series 3 (2005) 90-97
7. Sobin L.H., and Wittekind C. TNM Classification of prostate cancer. 6th ed. (2002), Wiley. Liss, New York p. 184-7
8. Ward J.F., Slezak J.M., Blute M.L., Bergstralh E.J., and Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 95 (2005) 751-756
9. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360 (2002) 103-108
10. Roach M., Lu J., Pilepich M.V., et al. Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys 47 (2000) 609-615
11. Roach M., Lu J., Pilepich M.V., et al. Predicting long-term survival, and the need for hformonal therapy: a meta-analysis of RTOG prostate cancer trials. Int J Radiation Oncol Biol Phys 47 (2000) 617-627
12. Akakura k., Isaka S., Akimoto S., et al. Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. Urology 54 (1999) 313-318
13. Bolla M., Van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
14. Martinez de la Riva S.I., Lopez-Tomasety J.B., Dominguez R.M., Cruz E.A., and Blanco P.S. Radical prostatectomy as monotherapy for locally advanced prostate cancer (T3a): 12 years follow-up. Arch Esp Urol 57 (2004) 679-692
15. Powell I.J., Tangen C.M., Miller G.J., et al. Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109. J Urol 168 (2002) 2016-2019
16. Sciarre A., Gentile V., Voria G., et al. Role of radical retropubic prostatectomy in patients with locally advanced prostate cancer: the influence of Gleason score 8-10. Uro Int 70 (2003) 186-194
17. Yamada A.H., Lieskovsky G., Petrovich Z., et al. Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer. Am J Clin Oncol 17 (1994) 277-285
18. Gerber G.S., Thisted R.A., Chodak G.W., et al. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institution pooled analysis. Eur Urol 32 (1997) 385-390
19. Van den Ouden D., Hop W.C.J., and Schroder F.H. Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy. J Urol 160 (1998) 1392-1397
20. Heidenreich A., and Ohlmann C.H. The role of anatomic extented pelvic lymphadenectomy in men undergoing radical prostatectomy for prostate cancer. EAU Update Series 3 (2005) 98-106
21. Partin A.W., Epstein J.I., Cho K.R., Gittelsohn A.M., and Walsh P.C. Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141 (1989) 341-345
22. Hachiya T., Ichinose T., Kobayashi K., Hirano D., and Okada K. Tumor volume and percentage of gland involvement with tumor as predictors of pathological stage in prostate cancer. Nippol Hinyokika Gakkai Zasshi 89 (1998) 546-551
23. McNeal J.E. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 23 (1992) 258-266
24. Kikuchi E., Scardino P.T., Wheeler T.M., Slawin K.M., and Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. J Urol 172 (2004) 508-511